HOME-SENSOVANN

SENSOVANN

Solutions for screening

Due to expertise and experience of the team, Sensovann has strategic focus on environmental water monitoring, facing threats posed by unsolved pollution, and also focus on microsensor solutions for chronic disease monitoring, cancer screening, among other screening areas in where demands of cost-effectiveness, sensitivity, and safe detection are present.

Sensovann is a R&D company devoted to microsystems based solutions for environmental and clinical screening applications. The organization has the aim to conquer unmeet challenges related to in-situ monitoring of bacteria, toxic chemicals, clinically relevant biomarkers, among other parameters of interest to user´s application.

R&D DIRECTION

——

Non-invasive rapid screening point-of-care system

The device is specifically made to provide a non-invasive solution for automatic sampling and testing urine samples.

Screening of chronic diseases

Sensovann provides technology solutions encompassing recognition of disease-specific biomarkers targeted in body fluids and user-friendly, safe analysis of biomarker data.

Screening chronic disease from non-invasive fluids

Sensovann team is devoted to R&D of biological microsystems for early detection and/or monitoring chronic diseases, including but not limited to Chronic Obstructive Pulmonary Disease, Heart Failure, Cancer, etc. The technology routes target disease-specific molecules present in body fluids and whose variations in concentration are indicative of disease diagnostics or status of diagnosed disease. Sensovann´s focus is to provide point-of-care (POC) solutions by electro-optical and electrochemical assays for the sensitive detection of clinically important biomarkers. POCs are accompanied to a machining learning algorithms run in a smartphone APP for precise analysis and user-friendly display of results. The company´s strategy is oriented to generation of IPR and formal certification of its devices. Our target customers are leading healthcare industries, hospitals and municipal primary care.